Tagraxofusp in Patients With CD123+ or With BPDCN-IPh-like Acute Myeloid Leukemia
Clinical trial NCT04342962 · TERMINATED
Trial details
- NCT number
- NCT04342962
- Sponsor
- Gruppo Italiano Malattie EMatologiche dell'Adulto
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-16
- Primary completion
- 2024-01-18
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.